Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Alnylam, MIT, Institute for Systems Biology, and More

Premium

Title: microRNA-based Methods and Compositions for the Diagnosis, Prognosis, and Treatment of Tumor Involving Chromosomal Rearrangements

Patent Number: 8,828,656

Filed: July 31, 2012

Lead Inventor: Joern Bullerdiek, University of Bremen


Title: Carbohydrate Conjugates as Delivery Agents for Oligonucleotides

Patent Number: 8,828,956

Filed: Dec. 4, 2012

Lead Inventor: Muthiah Manoharan, Alnylam Pharmaceuticals


Title: Methods and Compositions to Protect Aquatic Invertebrates from Disease

Patent Number: 8,828,961

Filed: Oct. 19, 2011

Lead Inventor: John Loy, Harrisvaccines


Title: siRNA Compositions and Methods for Potently Inhibiting Viral Infections

Patent Number: 8,828,962

Filed: Dec. 12, 2011

Lead Inventor: Bojian Zheng, Xiangxue Group


Title: Diagnosis and Treatment of Chronic Lymphocytic Leukemia

Patent Number: 8,828,963

Filed: March 16, 2012

Lead Inventor: David Galas, Institute for Systems Biology


Title: miR-150 for the Treatment of Blood Disorders

Patent Number: 8,828,965

Filed: Aug. 21, 2013

Lead Inventor: Jun Lu, Massachusetts Institute of Technology (Dana-Farber Cancer Institute)


Title: Immuno-RNA Constructs

Patent Number: 8,829,178

Filed: Dec. 21, 2006

Lead Inventor: Stefan Barth, Fraunhofer


Title: Means for Inhibiting the Expression of ANG2

Patent Number: 8,829,179

Filed: Feb. 18, 2010

Lead Inventor: Ansgar Santel, Silence Therapeutics


Title: Methods and Compositions for RNA Interference

Patent Number: 8,829,264

Filed: June 18, 2012

Lead Inventor: Gergory Hannon, Cold Spring Harbor Laboratory

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.